136 related articles for article (PubMed ID: 12916270)
1. [Influence of hormone replacement therapy (oral and transdermal) on activity of erythrocyte Zn/Cu superoxide dismutase (Zn/Cu-SOD) in postmenopausal women].
Radowicki S; Jankowska S; Kunicki M
Ginekol Pol; 2003 Apr; 74(4):282-7. PubMed ID: 12916270
[TBL] [Abstract][Full Text] [Related]
2. Trace mineral status in post menopausal women: impact of hormonal replacement therapy.
Bureau I; Anderson RA; Arnaud J; Raysiguier Y; Favier AE; Roussel AM
J Trace Elem Med Biol; 2002; 16(1):9-13. PubMed ID: 11878754
[TBL] [Abstract][Full Text] [Related]
3. Effects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in postmenopausal women.
Bednarek-Tupikowska G; Tworowska U; Jedrychowska I; Radomska B; Tupikowski K; Bidzinska-Speichert B; Milewicz A
Clin Endocrinol (Oxf); 2006 Apr; 64(4):463-8. PubMed ID: 16584521
[TBL] [Abstract][Full Text] [Related]
4. Reduction of activity, but no decrease in concentration, of erythrocyte Cu,Zn-superoxide dismutase by hyperglycaemia in diabetic patients.
Kotake M; Shinohara R; Kato K; Hayakawa N; Hayashi R; Uchimura K; Makino M; Nagata M; Kakizawa H; Nakagawa H; Nagasaka A; Itoh M
Diabet Med; 1998 Aug; 15(8):668-71. PubMed ID: 9702470
[TBL] [Abstract][Full Text] [Related]
5. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
Ichikawa J; Sumino H; Ichikawa S; Ozaki M
Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
[TBL] [Abstract][Full Text] [Related]
6. Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women.
Unfer TC; Figueiredo CG; Zanchi MM; Maurer LH; Kemerich DM; Duarte MM; Konopka CK; Emanuelli T
Climacteric; 2015 Jun; 18(3):379-88. PubMed ID: 25236970
[TBL] [Abstract][Full Text] [Related]
7. Participation of metallothionein and superoxide dismutase in the blood of smoking smelters.
Bizoń A; Milnerowicz H
Int J Occup Med Environ Health; 2014 Apr; 27(2):326-34. PubMed ID: 24692073
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and breast density changes.
Harvey J; Scheurer C; Kawakami FT; Quebe-Fehling E; de Palacios PI; Ragavan VV
Climacteric; 2005 Jun; 8(2):185-92. PubMed ID: 16096175
[TBL] [Abstract][Full Text] [Related]
9. Effects of inflammation and copper intake on rat liver and erythrocyte Cu-Zn superoxide dismutase activity levels.
DiSilvestro RA; Marten JT
J Nutr; 1990 Oct; 120(10):1223-7. PubMed ID: 2213250
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy.
Ruszkowska B; Sokup A; Kulwas A; Kwapisz J; Góralczyk K; Socha MW; Rhone P; Rość D
Acta Obstet Gynecol Scand; 2013 Jul; 92(7):841-6. PubMed ID: 23472599
[TBL] [Abstract][Full Text] [Related]
11. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
[TBL] [Abstract][Full Text] [Related]
13. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
14. The benefits of hormone replacement therapy on plasma and platelet antioxidant status and fatty acid composition in healthy postmenopausal women.
Gokkusu C; Tata G; Ademoğlu E; Tamer S
Platelets; 2010; 21(6):439-44. PubMed ID: 20459351
[TBL] [Abstract][Full Text] [Related]
15. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Kurtay G; Ozmen B; Erguder I
Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
[TBL] [Abstract][Full Text] [Related]
16. Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans.
Iskra M; Majewski W
Biol Trace Elem Res; 2000 Jan; 73(1):55-65. PubMed ID: 10949969
[TBL] [Abstract][Full Text] [Related]
17. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
[TBL] [Abstract][Full Text] [Related]
19. Trace element and magnesium levels and superoxide dismutase activity in rheumatoid arthritis.
Tuncer S; Kamanli A; Akçil E; Kavas GO; Seçkin B; Atay MB
Biol Trace Elem Res; 1999 May; 68(2):137-42. PubMed ID: 10327024
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy: relation to homocysteine and prooxidant-antioxidant status in healthy postmenopausal women.
Gökkuşu C; Özbek Z; Tata G
Arch Gynecol Obstet; 2012 Mar; 285(3):733-9. PubMed ID: 21877144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
